We are live on ! Find out more
SMTI icon

Sanara MedTech
SMTI

43 hedge funds and large institutions have $19.8M invested in Sanara MedTech in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.52% less ownership

Funds ownership: 7.96% → 7.44% (-0.52%)

9% less funds holding

Funds holding: 47 → 43 (-4)

26% less capital invested

Capital invested by funds: $26.7M → $19.8M (-$6.97M)

27% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 15

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
43
Holders Change
-4
Holders Change %
-8.51%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
15
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$341K
2
BlackRock
BlackRock
New York
+$328K
3
SIS
Strategic Investment Solutions
Illinois
+$240K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$180K
5
Lazard Asset Management
Lazard Asset Management
New York
+$97.3K

Top Sellers

Rank Fund Capital Flow
1
BAMCO Inc
BAMCO Inc
New York
-$590K
2
Citadel Advisors
Citadel Advisors
Florida
-$319K
3
Marshall Wace
Marshall Wace
United Kingdom
-$234K
4
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
-$221K
5
Rockefeller Capital Management
Rockefeller Capital Management
New York
-$221K
Name Holding Trade Value Shares
Change 		Change in
Stake
NA
51
NewEdge Advisors
Louisiana
– -$2.93K -73 Closed
C
52
Covestor
United Kingdom
– +$116 +3 New
1 2
3

SMTI Hedge Fund Activity: Q3 2023 in Review

43 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q3 2023, worth a combined $19.8M — down 26% from $26.7M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of SMTI and 5 opened new positions — a net loss of 4 holders — while 15 trimmed existing stakes and 11 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $341K. The largest seller was BAMCO Inc, exiting entirely with an estimated $590K sold.

  • 43 institutional investors held Sanara MedTech (SMTI) as of Q3 2023, down from 47 in Q2 2023.
  • Funds reported $19.8M of Sanara MedTech stock for Q3 2023, down 26% quarter-over-quarter.
  • 5 funds opened new Sanara MedTech positions in Q3 2023 and 9 closed out, a net change of -4 holders.
  • The largest Sanara MedTech buyer in Q3 2023 was Renaissance Technologies, an estimated $341K added.
  • The largest Sanara MedTech seller in Q3 2023 was BAMCO Inc, an estimated $590K sold.

Based on aggregated 13F filings for Q3 2023.